Alendronate Sodium
NDC 64980-340, Alendronate Sodium, tablet, from Rising Pharma Holdings, Inc..
- Product NDC
- 64980-340
- Status
- Listed
- Labeler
- Rising Pharma Holdings, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090124
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/64980-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALENDRONATE SODIUM10 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 64980-340-01 | 64980034001 | 100 TABLET in 1 BOTTLE (64980-340-01) |
| 64980-340-03 | 64980034003 | 30 TABLET in 1 BOTTLE (64980-340-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/ffdd2496-d253-419b-85a6-8c615f7545f1NADAC price for package 64980034001
GET /v1/drugs/nadac/64980034001NADAC price for package 64980034003
GET /v1/drugs/nadac/64980034003
Use it
Look up 64980-340 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/64980-340 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 64980-340. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.